Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-25-017694
Filing Date
2025-04-14
Accepted
2025-04-14 16:27:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 lenz-resale424b3.htm 424B3 162410
2 prospectuscover.jpg GRAPHIC 132972
  Complete submission text file 0001628280-25-017694.txt   320808
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286397 | Film No.: 25836341
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)